Response by Gibson and Fox to Letter Regarding Article, “Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We thank Dr Cerit for the question he poses regarding the association between syntax scores and outcomes in the PIONEER trial (An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment …